SectorBiological Technology
Established Date--
Listing Date09/03/2015
ExchangeNASDAQ Stock Exchange
Full-time Employees231
Fiscal Year Ends31/12
Security TypeCommon stock
Office address10865 Road to the Cure, Suite 150, San Diego, California 92121
Business
IntroductionCapricor Therapeutics, Inc., is incorporated in Delaware. The company is a biotechnology company focused on the development of cell and exosome therapies for the treatment of Duchenne muscular dystrophy. Its lead drug candidate, Deramiocel, is a cell therapy currently under FDA review for the treatment of cardiac and skeletal muscle complications of DMD.
